Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats

Environmental Toxicology and Pharmacology

Volumn 35, Issue 1, 2013, Pages 100-108

  Fouad, Amr A ^a   Al Mulhim, Abdulruhman S ^a   Jresat, Iyad ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Anti inflammatory; Antioxidant; Coenzyme Q10; Hepatocellular carcinoma; Rats

Indexed keywords

ALPHA FETOPROTEIN; CYCLOOXYGENASE 2; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEINASE ACTIVATED RECEPTOR 1; SUPEROXIDE DISMUTASE; TRICHLOROACETIC ACID; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DYSPLASIA; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ALPHA-FETOPROTEINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARCINOMA, HEPATOCELLULAR; CYCLOOXYGENASE 2; GLUTATHIONE; LIPID PEROXIDATION; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MALONDIALDEHYDE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TRICHLOROACETIC ACID; TUMOR NECROSIS FACTOR-ALPHA; UBIQUINONE;

RATTUS;

EID: 84871747414     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.11.016     Document Type: Article

References (43)

1. Abdel-Hamid N.M. Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats. J. Membr. Biol. 2009, 230:155-162.
2. Abdel-Hamid N.M., El-Moselhy M.A., El-Baz A. Hepatocyte lysosomal membrane stabilization by olive leaves against chemically induced hepatocellular neoplasia in rats. Int. J. Hepatol. 2011, 2011:736581.
3. Bahar M., Khaghani S., Pasalar P., Paknejad M., Khorramizadeh M.R., Mirmiranpour H., Nejad S.G. Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutr. J. 2010, 9:62.
4. 2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells. Life Sci. 2010, 86:214-223.
5. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007, 7(Suppl.):S41-S50.
6. Berasain C., Castillo J., Perugorria M.J., Latasa M.U., Prieto J., Avila M.A. Inflammation and liver cancer: new molecular links. Ann. N.Y. Acad. Sci. 2009, 1155:206-221.
7. Bishayee A., Barnes K.F., Bhatia D., Darvesh A.S., Carroll R.T. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev. Res. (Phila) 2010, 3:753-763.
8. Chu P.G., Ishizawa S., Wu E., Weiss L.M. Hepatocyte antigen as a marker of hepatocellular carcinoma. An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am. J. Surg. Pathol. 2002, 26:978-988.
9. Clancy R.M., Abramson S.B. Nitric oxide: a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 1995, 210:93-101.
10. Crane F.L. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 2001, 20:591-598.
11. DeAngelo A.B., Daniel F.B., Wong D.M., George M.H. The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J. Toxicol. Environ. Health A 2008, 71:1056-1068.
12. Du Q., Zhang X., Cardinal J., Cao Z., Guo Z., Shao L., Geller D.A. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res. 2009, 69:3764-3771.
13. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999, 340:745-750.
14. Fan Z., van de Rijn M., Montgomery K., Rouse R.V. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod. Pathol. 2003, 16:137-144.
15. Guerriero E., Sorice A., Capone F., Costantini S., Palladino P., D'ischia M., Castello G. Effects of lipoic acid, caffeic acid and a synthesized lipoyl-caffeic conjugate on human hepatoma cell lines. Molecules 2011, 16:6365-6377.
16. Hurlimann J., Gardiol D. Immunohistochemistry in the differential diagnosis of liver carcinomas. Am. J. Surg. Pathol. 1991, 15:280-288.
17. Jung H.J., Park E.H., Lim C.J. Evaluation of anti-angiogenic, anti-inflammatory and antinociceptive activity of coenzyme Q(10) in experimental animals. J. Pharm. Pharmacol. 2009, 61:1391-1395.
18. Kim J.M., Park E. Coenzyme Q10 attenuated DMH-induced precancerous lesions in SD rats. J. Nutr. Sci. Vitaminol. 2010, 56:139-144.
19. Lee J., Lim K.T. Preventive effect of phytoglycoprotein (38kDa) on expression of alpha-fetoprotein and matrix metalloproteinase-9 in diethylnitrosamine-treated ICR mice. Drug Chem. Toxicol. 2011, 10.3109/01480545.2011.600762.
20. Lenaz G., Fato R., Formiggini G., Genova M.L. The role of coenzyme Q in mitochondrial electron transport. Mitochondrion 2007, 7(Suppl.):S8-S33.
21. Leong A.S., Sormunen R.T., Tsui W.M., Liew C.T. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998, 33:318-324.
22. Love OaE R.G. Treatment of drinking water containing trichloroethylene and related industrial solvents. Am. Water Works Assoc. 1982, 74:413-425.
23. Lu X.L., He S.X., Ren M.D., Wang Y.L., Zhang Y.X., Liu E.Q. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: Involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2. Mol. Med. Report 2012, 5:637-644.
24. Ma Y., Wang J., Liu L., Zhu H., Chen X., Pan S., Sun X., Jiang H. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB. Cancer Lett. 2011, 301:75-84.
25. Mivervini M.I., Demetris A.J., Lee R.G., Carr B.I., Madariaga J., Nalesnik M.A. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod. Pathol. 1997, 10:686-692.
26. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 1994, 266:E829-E839.
27. Murakata L.A., Ishak K.G., Nzeako U.C. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod. Pathol. 2001, 13:874-881.
28. Ohshima H., Tatemichi M., Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 2003, 417:3-11.
29. Page G. Comparison of groundwater and surface water for levels of contamination by toxic substances. Environ. Sci. Technol. 1981, 15:1475-1481.
30. Perumal S.S., Shanthi P., Sachdanandam P. Combined efficacy of tamoxifen and coenzyme Q10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer. Mol. Cell. Biochem. 2005, 273:151-160.
31. Pogribny I.P., James S.J., Beland F.A. Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. Mol. Nutr. Food Res. 2012, 56:116-125.
32. Sakano K., Takahashi M., Kitano M., Sugimura T., Wakabayashi K. Suppression of azoxymethane-induced colonic premalignant lesion formation by coenzyme Q10 in rats. Asian Pac. J. Cancer Prev. 2006, 7:599-603.
33. Schmelzer C., Lorenz G., Lindner I., Rimbach G., Niklowitz P., Menke T., Döring F. Effects of coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines. Biofactors 2007, 31:35-41.
34. Schmelzer C., Lindner I., Rimbach G., Niklowitz P., Menke T., Döring F. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 2008, 32:179-183.
35. Shukla R., Yue J., Siouda M., Gheit T., Hantz O., Merle P., Zoulim F., Krutovskikh V., Tommasino M., Sylla B.S. Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling. Carcinogenesis 2011, 32:978-985.
36. Sohet F.M., Neyrinck A.M., Pachikian B.D., de Backer F.C., Bindels L.B., Niklowitz P., Menke T., Cani P.D., Delzenne N.M. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem. Pharmacol. 2009, 78:1391-1400.
37. Tabor E. Hepatocellular carcinoma: global epidemiology. Dig. Liver Dis. 2001, 33:115-117.
38. Tao L., Yang S., Xie M., Kramer P.M., Pereira M.A. Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: prevention by methionine. Toxicol. Sci. 2000, 54:399-407.
39. Tsuneki H., Sekizaki N., Suzuki T., Kobayashi S., Wada T., Okamoto T., Kimura I., Sasaoka T. Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur. J. Pharmacol. 2007, 566:1-10.
40. Ueno S., Aoki D., Kubo F., Hiwatashi K., Matsushita K., Oyama T., Maruyama I., Aikou T. Roxithromycin inhibits constitutive activation of nuclear factor {kappa}B by diminishing oxidative stress in a rat model of hepatocellular carcinoma. Clin. Cancer Res. 2005, 11:5645-5650.
41. Wennerberg A.E., Nalesnic M.A., Coleman W.B. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepato- cytes and can be used for differential diagnosis of hepatic tumors. Am. J. Pathol. 1993, 143:1050-1054.
42. Yokoo H., Yasuda J., Nakanishi K., Chuma M., Kamiyama T., Todo S., Hirohashi S., Sakamoto M. Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma. Hepatol. Res. 2011, 41:240-249.
43. 4-induced acute liver injury of mice. Free Radic. Biol. Med. 2000, 29:870-880.